Syngene International Limited
NSE:SYNGENE.NS
898.45 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Syngene International Limited |
Symbool | SYNGENE.NS |
Munteenheid | INR |
Prijs | 898.45 |
Beurswaarde | 360,541,968,080 |
Dividendpercentage | 0.11% |
52-weken bereik | 607.65 - 945.25 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonathan Brittan Hunt |
Website | https://www.syngeneintl.com |
An error occurred while fetching data.
Over Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)